Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.read more »How we assessed the access potential of a new product in order to develop a successful launch strategy
Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.read more »How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America
Our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.read more »
- Our latest white papersEmerging Markets: Your New Essential Guide
Request your complimentary copy of our latest Emerging Markets guide.read more »Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations
In this paper we examine the differences between behavioural and attitudinal approaches to segmentation and outline how integration of the two can best be achieved to strengthen segmentation solutionsread more »